Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Artificial Intelligence In Oncology Market Size Outlook: How Fast Will Revenue Grow Through 2030?

In the realm of artificial intelligence within oncology, a significant expansion has been observed lately. Projections indicate a leap from a market valuation of $2.35 billion in 2025 to $3.13 billion in 2026, propelled by a formidable compound annual growth rate of 33.4%. This impressive growth trajectory in the preceding period has been fueled by a confluence of factors including the escalating worldwide prevalence of cancer, the proliferation of research endeavors focused on oncology, a broader uptake of digital pathology methodologies, an increased reliance on diagnostic tools informed by data analytics in cancer care, and substantial investments made in sophisticated oncology infrastructure.

The oncology sector’s artificial intelligence market is poised for remarkable expansion in the coming years, projecting a valuation of $10.25 billion by 2030 with a compound annual growth rate (CAGR) of 34.5%. This upward trajectory is fueled by several key factors, including the wider embrace of precision oncology approaches, a heightened demand for tailored cancer treatments, the expanded application of AI within clinical oncology studies, greater synergy between genomic data and AI systems, and increased funding directed towards AI ventures specializing in oncology. Significant developments anticipated during this period encompass the greater utilization of AI-powered tools for cancer identification, the increased application of AI in refining treatment strategies, the accelerated integration of AI into the pharmaceutical research and development pipeline for cancer drugs, the proliferation of predictive analytics in oncology, and a reinforced emphasis on leveraging AI for precision oncology initiatives.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

Artificial Intelligence In Oncology Market Growth Drivers: What Factors Are Accelerating Expansion?

Anticipated increases in cancer diagnoses are poised to stimulate the expansion of the AI in oncology sector moving ahead. This complex category of illnesses is defined by the unrestricted proliferation and multiplication of aberrant cells within the organism. The incorporation of artificial intelligence into the field of oncology offers the capability to transform cancer treatment paradigms, enhancing accuracy, tailoring interventions, and boosting overall efficacy. Illustratively, statistics from the American Cancer Society Inc., a non-profit health entity headquartered in the US, indicated a rise in projected new cancer cases from 1.8 million to 1.9 million in 2023. Consequently, this upward trend in cancer occurrences is serving as a primary catalyst for the burgeoning AI in oncology market.

#Artificial Intelligence In Oncology Market Segment Landscape And Growth Potential

The artificial intelligence in oncology market covered in this report is segmented –

1) By Component: Software Solutions, Hardware, Services

2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types

3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types

4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications

5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms

2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems

3) By Services: Consulting Services, Integration Services, Maintenance And Support Services

Artificial Intelligence In Oncology Market Trends: What Is Shaping Future Industry Growth?

Leading players within the AI in oncology market are concentrating their efforts on creating cutting-edge software solutions, including cloud-based platforms, to boost effectiveness and deliver superior outcomes. These cloud-based software offerings are instrumental in oncology AI by furnishing a robust, adaptable, and readily available environment for the complex processing and examination of extensive medical datasets. As an illustration, Illumina Inc., a prominent US biotechnology firm, introduced Connected Insights in March 2023, a novel cloud-based software designed to facilitate advanced analysis specifically for oncology applications. By incorporating external knowledge repositories, Connected Insights simplifies the interpretation and reporting of outcomes derived from diverse assay methodologies, thereby empowering laboratories to broaden their adoption of Next-Generation Sequencing (NGS) and accelerate the delivery of clinical reports.

Artificial Intelligence In Oncology Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the artificial intelligence in oncology market are Azra AI, IBM Corporation, Siemens Healthcare GmbH, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Proscia Inc., Deep 6 AI Inc., Intel Corporation, Zebra Medical Vision, Ibex Medical Analytics, Nanox Imaging Ltd., Berg LLC

Access The Complete Artificial Intelligence In Oncology Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

Artificial Intelligence In Oncology Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the AI in oncology market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model